Clinical Outcomes of Endoscope-Assisted Vitreous Surgery for Giant Retinal Tear Detachment.


Journal

Ophthalmic research
ISSN: 1423-0259
Titre abrégé: Ophthalmic Res
Pays: Switzerland
ID NLM: 0267442

Informations de publication

Date de publication:
2021
Historique:
received: 28 01 2021
accepted: 19 05 2021
pubmed: 2 6 2021
medline: 12 2 2022
entrez: 1 6 2021
Statut: ppublish

Résumé

With the advent of perfluorocarbon liquid (PFCL), the success rate of refractory giant retinal tear (GRT) detachment has dramatically improved. PFCL is a very effective tool when used properly, but in GRT detachment, it may move under the retina through the tear, so it is necessary to devise ways to prevent PFCL from migrating under the retina. Ophthalmic endoscope-assisted vitrectomy may reduce the risk of subretinal migration of PFCL, facilitate safer use of PFCL, and increase the success rate of GRT detachment. The present study aimed to describe the clinical outcomes of endoscope-assisted vitreous surgery for giant retinal detachment. Twenty consecutive eyes from 19 patients who had undergone endoscope-assisted vitreous surgery for treatment of a GRT detachment were enrolled. Subretinal fluid drainage, extension of the rolled GRT, and endophotocoagulation under air were performed with the aid of an endoscope, without the use of PFCL. Where necessary, extension of a fixed retinal fold and internal limiting membrane peeling was performed with PFCL. The initial and final retinal reattachment rates were 90 and 95%, respectively. In 3 eyes, a small amount of PFCL was used, and there were no PFCL remnants. The mean follow-up duration was 18 months (range, 3-69 months). After surgery, the mean best-correlated visual acuity significantly improved from 20/514 to 20/41 (p = 0.0008). Endoscope-assisted vitreous surgery for giant retinal detachment has favourable clinical outcomes for visual acuity and retinal detachment.

Identifiants

pubmed: 34062537
pii: 000517353
doi: 10.1159/000517353
doi:

Substances chimiques

Fluorocarbons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

820-827

Informations de copyright

© 2021 The Author(s) Published by S. Karger AG, Basel.

Auteurs

Hayato Mitamura (H)

Department of Ophthalmology, Iida Municipal Hospital, Iida, Japan.
Department of Ophthalmology, Japan Community Health Care Organization Chukyo Hospital, Nagoya, Japan.
Chukyo Eye Clinic, Nagoya, Japan.

Tatsushi Kaga (T)

Department of Ophthalmology, Japan Community Health Care Organization Chukyo Hospital, Nagoya, Japan.

Sho Yokoyama (S)

Department of Ophthalmology, Japan Community Health Care Organization Chukyo Hospital, Nagoya, Japan.

Takashi Kojima (T)

Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.

Toshio Mori (T)

Department of Ophthalmology, Iida Municipal Hospital, Iida, Japan.

Taisuke Matsuda (T)

Department of Ophthalmology, Japan Community Health Care Organization Chukyo Hospital, Nagoya, Japan.

Hiroyuki Sato (H)

Satoh Yuya Eye Clinic, Sendai, Japan.

Norihiko Yoshida (N)

Department of Ophthalmology, Japanese Red Cross Gifu Hospital, Gifu, Japan.

Kazuo Ichikawa (K)

Chukyo Eye Clinic, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH